pepmg_

Study summary · research use only

In vitro effect of short peptides on expression of interleukin-2 gene in splenocytes

Observational · animal · Bulletin of experimental biology and medicine · 2002 · DOI 10.1023/a:1020210615148 · PMID 12447482

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

This study examined splenocytes from CBA mice in vitro, testing the synthetic peptides Vilon (Lys-Glu), Epithalon (Ala-Glu-Asp-Gly), and Cortagen (Ala-Glu-Asp-Pro) on interleukin-2 gene expression. All three peptides activated interleukin-2 mRNA synthesis without added inducers, with intensity depending on peptide type, concentration, and treatment duration. Vilon and Epithalon produced the most pronounced responses, while Cortagen produced a less pronounced response on interleukin-2 mRNA synthesis.

Abstract

Synthetic peptides Vilon (Lys-Glu), Epithalon (Ala-Glu-Asp-Gly), and Cortagen (Ala-Glu-Asp-Pro) in vitro activated interleukin-2 mRNA synthesis in splenocytes from CBA mice in the absence of specific inductors. The intensity of interleukin-2 mRNA synthesis in splenocytes depended on the type, concentration, and duration of treatment with the peptides. Vilon and Epithalon were most potent, while Cortagen produced a less pronounced effect on interleukin-2 mRNA synthesis.

Read the full study on PubMed ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.